Ovobel Foods Limited

Consumer Defensive — Packaged Foods · BSE

₹303.30−₹7.10 (−2.29%)

DalalBaazaar Score

60 / 100

🟢 Good

Verdict

NEUTRAL

Risk

Moderate

Driven by micro-cap size, which brings thin liquidity, a beta above 1.3, so it swings harder than the index.

In simple words: Strong business and financial position, with both sales and profits growing well. Nothing obvious stands out as stretched — the usual checks on business quality and management still apply.

Decision support, not a buy or sell call.

As of 18 Oct 2026, 6:58 pm

Understanding the Business

Company site ↗

The 60-second version of Ovobel Foods Limited — what it does, how it earns, and who it competes with, before any of the numbers below.

What does this company do?

Ovobel Foods Limited manufactures and distributes egg powder and other egg related products in India. The company offers processed egg products, including whole egg powder, egg yolk powder, egg white powder, and pasteurized frozen egg.

IndustryPackaged Foods

SectorConsumer Defensive

Employees128

Annual revenue₹257 Cr

How does it make money?

Turns over ₹257 Cr a year. Of every ₹100 of sales, about ₹9 reaches shareholders as profit, with ₹16 left at the operating level before interest, tax and depreciation. Each of its 128 employees supports ₹2.00 Cr of revenue a year, the signature of a capital- or asset-led business.

Revenue / employee₹2.00 Cr

Who are its competitors?

The closest listed comparisons in its industry are NESTLE INDIA LIMITED, BRITANNIA INDUSTRIES LTD, TATA CONSUMER PRODUCT LTD, DABUR INDIA LTD. These are the companies its valuation and returns are measured against elsewhere in this report.

Compared side by side in Peers ↓

What is its competitive advantage?The numbers suggest a real one

ROCE has stayed above 15% in every year available and stands at 30.6%. Returns that high normally get competed away; when they persist, something is protecting them, and its ROE of 22.1% against a peer median of 51.0% is consistent with that. What that something is — brand, scale, switching costs, regulation — the accounts cannot tell you.

Peer median ROE51.0%

What has been driving growth?

Profit has moved mainly because margins changed, not because the business sold much more. Over 3 years revenue moved +16% while net margin moved -46% relative to itself. What this cannot tell you is which products, customers or geographies did the work — that lives in the segment disclosures of the annual report.

Revenue effect+16%

Margin effect-46%

DalalBaazaar Score

60/ 100

Good

Weighted across six categories. Every point is explained below.

✗ Beta of 1.72 — amplifies market moves in both directions
✗ Micro Cap: thinner liquidity and sharper drawdowns are normal
✗ Profits have swung sharply from year to year — earnings are hard to forecast

Quality vs. Valuation

Company Quality

62/ 100

Average

How good the business is, ignoring the share price entirely.

Valuation

77/ 100

Cheap

What you are being asked to pay, ignoring how good the business is.

A reasonable business at a reasonable price — neither the quality nor the valuation stands out in either direction.

Historical Valuation

Current P/E

7.3x

3Y Median

6.9x

40 monthly readings · mean 9.8x · range 3.2x–21.5x

Sector Median

51.7x

median of 4 sector peers

🟡Currently trading close to its 3y median of 6.9x — the market is paying about what it usually pays for this company.

🟢Against its sector it trades 86% below the peer median of 51.7x.

vs. its own history

Fair

6.9x median over 40 months · +6%

vs. sector peers

Cheap

51.7x median of 4 peers · -86%

vs. generic bands

Cheap

Below 15x

EV/EBITDA

7.7x

PEG

—

What's Good / What's Bad

🟢 What's Going Well3

High return on capital employed
ROCE of 30.6% is the mark of a business that converts capital into profit efficiently.
Very low debt
Debt/Equity of 0.26x leaves the balance sheet with plenty of headroom.
Consistently profitable
Profitable in every one of the last 4 reported years.

🔴 What Needs Attention2

Return on equity is falling
ROE has dropped from 65.9% to 22.1% — each rupee of shareholder capital earns less than it did.
Return on capital is falling
ROCE has declined from 87.4% to 30.6% — often a sign of competition or overexpansion.

Red Flags

3 items require attention · 2 high · 1 watch

🔴Significant margin compressionFinancial
EBITDA margin has fallen 9.1 points, from 24.7% to 15.7%.
🔴Inventory building faster than salesFinancial
Inventory up 109% against revenue up 16% — stock may not be moving.
🟡Profit is decliningFinancial
Net profit is down 37% over 3 years.

Investment Thesis

🟢 Bull CaseWhat could make this work?

Capital compounds at a high rate
ROCE of 30.6% means each rupee reinvested earns well above what capital costs. If the company can keep deploying at this rate, growth creates value rather than just consuming cash.
Cheaper than its peers
It trades 86% below the sector median. Either the market sees a problem the numbers do not show, or the discount closes.
Self-funding with balance-sheet headroom
Positive free cash flow of ₹24 Cr alongside low debt means growth, buybacks or dividends need no outside money — and a downturn can be absorbed rather than refinanced.
Earnings have proved durable
Profitable in every one of the last 4 reported years. Consistency lowers the risk that any single bad year is structural rather than cyclical.

🔴 Bear CaseWhat could go wrong?

Margins are being competed away
EBITDA margin has fallen from 24.7% to 15.7%. If the trend continues, profit falls even on flat sales — and margin decline rarely reverses quickly.
Growth barely outpaces inflation
Revenue compounding at 5.1% a year is close to the rate prices rise, so the business is gaining little ground in real terms. That leaves the share price dependent on a re-rating rather than on earnings growth.
Returns on shareholder capital are falling
ROE has dropped from 65.9% to 22.1%. Each rupee of equity earns less than it did, so profit growth increasingly depends on raising more capital rather than on the existing base working harder.
Earnings are hard to forecast
Profit has swung sharply from year to year, so any single year — good or bad — is a weak guide to the next. Cyclical earnings deserve lower multiples for that reason.
Size brings its own risk
Micro Cap businesses are thinly traded, so exits are harder in a falling market and single events move the price more than they would for a larger company.

🟡 Key Things to WatchMeasurable tripwires, set against where this company stands today

1EBITDA margin holds above 14%✓ 15.7%
Two points below today's level — enough room for noise, tight enough to catch real compression.
2Revenue growth stays above 4% a year✓ 5.1% CAGR
Latest reported year was 31.8%. The bar is set below the established compounding rate, so ordinary variation does not trip it.
3Free cash flow remains positive✓ ₹24 Cr
Profit that never becomes cash eventually stops being profit.
4Debt / EBITDA stays below 2x✓ 0.7x
The ratio lenders write covenants against; it survives a small or negative equity base, unlike Debt/Equity.
5ROCE stays above 28%✓ 30.6%
Falling returns on capital are usually competition arriving, and show up here before they reach the margin.

Investment Checklist

11 / 11 checks passed

✓ Strong return on equity (ROE ≥ 15%)
✓ Strong return on capital employed (ROCE ≥ 15%)
✓ Healthy net margin (≥ 10%)
✓ Generates positive free cash flow
✓ Manageable leverage (Debt/Equity < 1.0)
✓ Adequate short-term liquidity (Current Ratio ≥ 1.0)
✓ Revenue growing year-over-year
✓ Profit growing year-over-year
✓ Not trading at an extreme valuation (P/E < 40x)
✓ Not buying right at the 52-week high
✓ Short-term technical trend isn't bearish

Price history

Quick Metrics

8 good · 3 neutral · 0 weak

Market Cap

₹288 Cr

Micro Cap

Smaller company — thin liquidity and deep drawdowns are normal here

P/E (Trailing)

7.3x

Cheap

Cheap against the generic band

P/B Ratio

2.62x

Fair

Moderate premium to the company's book value

EPS (TTM)

₹41.33

Profitable

Profitable on a per-share basis

ROE

22.1%

Strong

Strong capital efficiency

ROCE

30.6%

Strong

Earns comfortably above its likely cost of capital

Debt/Equity

0.26x

Low

Conservative leverage

Revenue Growth (YoY)

31.8%

Healthy

Healthy top-line growth

Profit Growth (YoY)

459.0%

Healthy

Profits growing at a healthy clip

Dividend Yield

None

No dividend yield reported — usually means no payout, but verify if one was recently initiated

Free Cash Flow

₹24 Cr

Cash generative

Generates cash even after funding its capex

More Metrics

Operating Margin

21.5%

Good

Healthy core-business profitability

Net Margin

13.4%

Good

Strong bottom-line conversion

Current Ratio

2.45

Comfortable

Healthy short-term liquidity

Beta (vs Nifty)

1.72

High swing

Swings more than the market in both directions

52W Range Position

81%

Mid-range

Technical Snapshot

SMA 20 / SMA 50

279.6 / 256.1

Bullish alignment (short > long)

Price vs SMA 200

Above

Long-term uptrend

RSI (14)

60.5

Neutral momentum

Financial Trend (4-Year)

Metric	FY23	FY24	FY25	FY26	3Y CAGR
Revenue	₹221 Cr	₹174 Cr	₹188 Cr	₹257 Cr	+5.1%
EBITDA	₹55 Cr	₹26 Cr	₹16 Cr	₹40 Cr	-9.8%
EBITDA Margin	24.7%	15.1%	8.4%	15.7%	—
PAT (Net Profit)	₹39 Cr	₹18 Cr	₹9 Cr	₹24 Cr	-14.4%
EPS	₹40.86	₹18.83	₹9.53	₹25.63	-14.4%
ROE	65.9%	23.3%	10.6%	22.1%	—
ROCE	87.4%	32.1%	15.5%	30.6%	—
Total Debt	₹29 Cr	₹19 Cr	₹27 Cr	₹29 Cr	-0.4%
Free Cash Flow	₹40 Cr	-₹8 Cr	-₹11 Cr	₹24 Cr	-16.3%

🟢 Revenue has grown at 5.1% a year over 3 years.

🔴 EBITDA has shrunk at 9.8% a year over 3 years.

🔴 EBITDA Margin has fallen from 24.7% to 15.7% over 3 years (-9.1 pts).

🔴 PAT (Net Profit) has shrunk at 14.4% a year over 3 years.

🔴 EPS has shrunk at 14.4% a year over 3 years.

🔴 ROE has fallen from 65.9% to 22.1% over 3 years (-43.8 pts).

🔴 ROCE has fallen from 87.4% to 30.6% over 3 years (-56.8 pts).

🟡 Total Debt has been broadly flat over 3 years (-0.4% a year).

🔴 Free Cash Flow has shrunk at 16.3% a year over 3 years.

Balance Sheet & Cash Flow — FY2026

Total Assets

₹169 Cr

Total Liabilities

₹59 Cr

Cash & Equivalents

₹6 Cr

Operating Cash Flow

₹30 Cr

Capex

-₹7 Cr

Shareholding (proxy)

Institutional Holding

0.0%

Insider Holding

69.6%

Peer Comparison

Company	P/E	ROE
NESTLE INDIA LIMITED	59.8x	79.9%
BRITANNIA INDUSTRIES LTD	44.1x	51.0%
TATA CONSUMER PRODUCT LTD	59.3x	7.5%
DABUR INDIA LTD	34.7x	17.2%

Recent News

1 positive5 general

Ovobel Foods Upper Circuit Today: Price, Data and Peers

Univest, 09 Oct

Ovobel Foods Limited Clarifies No Material Information Behind Recent Price Movement

scanx.trade, 16 Apr

Ovobel Foods standalone net profit rises 460.00% in the June 2026 quarter

Business Standard, 11 AugResults

🟢Potentially positiveReported improvement. Check whether it came from volume, price or a one-off item before treating it as a trend.

Ovobel Foods Ltd. Peer Comparison – Compare with Others

Value Research, 31 Aug

Ovobel Foods Ltd is Rated Strong Buy

MarketsMojo, 05 Oct

Ovobel Foods Ltd. Shareholding Pattern – Promoters, FIIs & DIIs

Value Research, 01 Sept

Watch Items

Cross-check against the company's latest quarterly filing / investor presentation before acting.

DalalBaazaar Thesis

StrongFinancial Health · Profitability · Valuation

MiddlingBusiness Quality

WeakGrowth · Risk

Points for each in the Score ↑

Unremarkable in both directions

A reasonable business at a reasonable price. Nothing here is alarming and nothing is compelling, which usually means the decision rests on things this data cannot see — the industry's direction, management's intent, and what else is available to you. 2 high-severity red flags sit above this conclusion and should be read first.

All 5 tripwires holding · see Key things to watch ↑